Latest filing published 06 Aug 2021 for Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.), €168k.
This profile gathers the share dealings of Richard Urbain DE SCHUTTER in Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.). In total, 8 filings cover trades dated from 13 September 2018 to 4 August 2021.
The open-market record is one-sided, with 3 purchases worth €2.2M and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 3 option exercises. Since January 2021: 1 purchase and no sales on the market.
The median purchase comes to €168k. The 3 purchases reviewed show no overlap with other insiders buying the same stock within a month.
The latest filing, published on 6 August 2021, reports an open-market purchase of €168k in Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.). The median gap between a trade and its publication by SEDI is 5 days. This delay matters because a trade only becomes useful information once it is public. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations